Schoeberl, Birgit
Harvard University · Massachusetts General Hospital · Dana-Farber Cancer Institute · Dana-Farber/Harvard Cancer Center · Cell Signaling Technology (United States)
3 papers on CoChatORCID 0000-0002-1990-5315
Most cited papers
- Verified
Systems biology and combination therapy in the quest for clinical efficacy
Fitzgerald, J. B., Schoeberl, B., Nielsen, U. B., & Sorger, P. K. (2006) · Nature Chemical Biology
Computational Drug Discovery MethodsGene Regulatory Network Analysis
Cited by 570
- Verified
Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data
Chen, W. W., Schoeberl, B., Jasper, P. J., Niepel, M., Nielsen, U. B., Lauffenburger, D. A., & Sorger, P. K. (2009) · Molecular Systems Biology
HER2/EGFR in Cancer ResearchGene Regulatory Network Analysis
Cited by 391
- Verified
An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation
Schoeberl, B., Faber, A. C., Li, D., Liang, M.-C., Crosby, K., Onsum, M., Burenkova, O., Pace, E., Walton, Z., Nie, L., et al. (2010) · Cancer Research
HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations
Cited by 264
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free